News
AI Health Law & Policy: Comparing regulatory landscapes for AI in medical devices in the EU and U.S.
Artificial intelligence is transforming the medical device industry, offering unprecedented opportunities to enhance patient care. However, ...
Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...
Creyon Bio, Inc. ("Creyon") today announced a global licensing and multi-target research collaboration with Eli Lilly and Company ("Lilly") focused on the discovery, development and commercialization ...
In 2025, pharmacy leaders are grappling with a billion-dollar question: how to deliver high-quality, patient-centered care amid financial strain, policy uncertainty, and rapid technological change.
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results